News reports, referencing Bloomberg, point to Bain Capital looking to acquire PCI Pharma Services for US$10bn. PCI Pharma is a US-based global CDMO backed by Kohlberg, Mubadala Investment Company and funds managed by Partners Group. US-based PE firm, Kohlberg, acquired its majority stake in 2020 & Company, LLC (“Kohlberg”) a majority stake in the company. Abu Dhabi sovereign investor Mubadala and Partners Group have minority shares in the company. Bain is seeking a majority stake in the company, say the reports.
Read the full article: US: News Reports Point to Bain Seeking Majority Stake in PCI Pharma //
Source: https://www.investorsinhealthcare.com/articles/category/news/us-news-reports-point-to-bain-seeking-majority-stake-in-pci-pharma/